YTHDF1 and neoplasm: Furthermore, experimental results have shown that combining YTHDF1 knockout with anti-PD-1 immune checkpoint inhibitor therapy significantly improves treatment efficacy and reduces the tumor’s resistance to immune checkpoint inhibitors [109].